BCM
EVH icon

Brasada Capital Management’s Evolent Health EVH Stock Holding History

Brasada Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,000
Closed -$29K – 297
2018
Q1 		$29K Hold
2,000
– – 0.01% 207
2017
Q4 		$25K Buy
+2,000
New +$28.2K 0.01% 214

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Brasada Capital Management's EVH Position: Q2 2018 in Review

Brasada Capital Management sold out of Evolent Health (EVH) in Q2 2018, closing a stake of 2,000 shares — an estimated $29K sold.

Brasada Capital Management first reported a position in EVH in Q4 2017 and held it in 2 quarters. The position peaked at $29K in Q1 2018. 178 funds tracked by Wall St. Rank hold EVH as of Q2 2018.

  • Brasada Capital Management reported no remaining Evolent Health position as of Q2 2018 after selling out during the quarter.
  • Brasada Capital Management sold 2,000 Evolent Health shares in Q2 2018, an estimated $29K.
  • Brasada Capital Management first reported a position in Evolent Health in Q4 2017 and held it in 2 quarters.
  • Brasada Capital Management's Evolent Health position peaked at $29K in Q1 2018.
  • 178 funds tracked by Wall St. Rank held Evolent Health as of Q2 2018.

Based on Brasada Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.